Prospective Investigation of Antithrombin III Deficiency in Adult Patients With ECMO
Condition(s):Antithrombin III Deficiency; Extracorporeal Membrane Oxygenation ComplicationLast Updated:May 24, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Antithrombin III Deficiency; Extracorporeal Membrane Oxygenation ComplicationLast Updated:May 24, 2022Completed
Condition(s):Liver Transplantation and AntithrombinLast Updated:June 3, 2021Completed
Condition(s):Congenital Antithrombin DeficiencyLast Updated:October 19, 2023Recruiting
Condition(s):Acquired Antithrombin DeficiencyLast Updated:February 1, 2024Not yet recruiting
Condition(s):Antithrombin III Deficiency; Covid19Last Updated:September 7, 2022Terminated
Condition(s):Thrombophilia Due to Acquired Antithrombin III DeficiencyLast Updated:July 15, 2015Terminated
Condition(s):Antithrombin III DeficiencyLast Updated:September 26, 2017Withdrawn
Condition(s):Extracorporeal Membrane OxygenationLast Updated:May 17, 2019Completed
Condition(s):Antithrombin III DeficiencyLast Updated:November 29, 2023Not yet recruiting
Condition(s):Liver Transplant; ComplicationsLast Updated:July 1, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.